Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

Published:2011-09-15 Issue:11 Volume:365 Page:1014-1024
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Sherman Kenneth E.,Flamm Steven L.,Afdhal Nezam H.,Nelson David R.,Sulkowski Mark S.,Everson Gregory T.,Fried Michael W.,Adler Michael,Reesink Hendrik W.,Martin Marie,Sankoh Abdul J.,Adda Nathalie,Kauffman Robert S.,George Shelley,Wright Christopher I.,Poordad Fred

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1014463

Cited by 663 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes;Scientific Reports;2024-03-07

2. Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation;Gastroenterology Insights;2023-06-29

3. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C;World Journal of Gastroenterology;2023-02-14

4. Advances in covalent drug discovery;Nature Reviews Drug Discovery;2022-08-25

5. Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir;Biochemistry and Biophysics Reports;2022-07